175 related articles for article (PubMed ID: 16640741)
21. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus.
Font J; Ramos-Casals M; Brito-Zerón P; Nardi N; Ibañez A; Suarez B; Jiménez S; Tàssies D; García-Criado A; Ros E; Sentís J; Reverter JC; Lozano F
Rheumatology (Oxford); 2007 Jan; 46(1):76-80. PubMed ID: 16801331
[TBL] [Abstract][Full Text] [Related]
22. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus.
Sada KE; Yamasaki Y; Maruyama M; Sugiyama H; Yamamura M; Maeshima Y; Makino H
J Rheumatol; 2006 Aug; 33(8):1545-52. PubMed ID: 16881111
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
Peros E; Geroldi D; Bugatti S; Caporali R; Rossi P; Montecucco C; D'Angelo A; Emanuele E
Int J Mol Med; 2005 Apr; 15(4):661-5. PubMed ID: 15754029
[TBL] [Abstract][Full Text] [Related]
24. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
[TBL] [Abstract][Full Text] [Related]
25. Elevated blood viscosity in systemic lupus erythematosus.
Rosenson RS; Shott S; Katz R
Semin Arthritis Rheum; 2001 Aug; 31(1):52-7. PubMed ID: 11503139
[TBL] [Abstract][Full Text] [Related]
26. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
Sarkissian T; Beyenne J; Feldman B; Adeli K; Silverman E
Arthritis Rheum; 2006 Apr; 54(4):1283-90. PubMed ID: 16575849
[TBL] [Abstract][Full Text] [Related]
27. [Association of cardiovascular risk factors and small arterial elasticity].
Li XL; Jiang SH; Zhang HF; Wang ZZ; Huang J
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):37-40. PubMed ID: 15924776
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery disease in systemic lupus erythematosus: A review of the literature.
Karrar A; Sequeira W; Block JA
Semin Arthritis Rheum; 2001 Jun; 30(6):436-43. PubMed ID: 11404827
[TBL] [Abstract][Full Text] [Related]
29. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
[TBL] [Abstract][Full Text] [Related]
30. Acquired activated protein C resistance, high tissue factor expression, and hyper-homocysteinemia in systemic lupus erythematosus.
Oh D; Kim SH; Kang MS; Kim NK; Chang NS; Na BW; Chung SY; Park S; Cho CS
Am J Hematol; 2003 Feb; 72(2):103-8. PubMed ID: 12555213
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of paraoxonase activity and lipid profile in lupus patients].
Kiss E; Seres I; Zsolt K; Tarr T; Csípo I; Szegedi G; Paragh G
Orv Hetil; 2005 Nov; 146(47):2395-402. PubMed ID: 16398152
[TBL] [Abstract][Full Text] [Related]
32. Endothelium and angiogenesis in white coat hypertension.
Karter Y; Aydin S; Curgunlu A; Uzun H; Ertürk N; Vehid S; Kutlu A; Simsek G; Yücel R; Arat A; Ozturk E; Erdine S
J Hum Hypertens; 2004 Nov; 18(11):809-14. PubMed ID: 15215878
[TBL] [Abstract][Full Text] [Related]
33. Premature atherosclerotic disease in systemic lupus erythematosus--role of inflammatory mechanisms.
Rhew EY; Ramsey-Goldman R
Autoimmun Rev; 2006 Feb; 5(2):101-5. PubMed ID: 16431336
[TBL] [Abstract][Full Text] [Related]
34. Arterial compliance: is it reduced in antiphospholipid syndrome?
Reitblat T; Polishchuk I; Zamir D; Isakov I; Oren S
J Hum Hypertens; 2006 Jul; 20(7):504-9. PubMed ID: 16625240
[TBL] [Abstract][Full Text] [Related]
35. [Atherogenic cholesterol-containing circulating immune complexes--one of the components of the serum in patients with systemic lupus erythematosus].
Gerasimova EV; Alekberova ZS; Popkova TV; Sobenin IA
Klin Med (Mosk); 2003; 81(9):39-41. PubMed ID: 14598590
[TBL] [Abstract][Full Text] [Related]
36. 8-Isoprostaglandin F2 alpha: a potential index of lipid peroxidation in systemic lupus erythematosus.
Abou-Raya A; el-Hallous D; Fayed H
Clin Invest Med; 2004 Dec; 27(6):306-11. PubMed ID: 15675110
[TBL] [Abstract][Full Text] [Related]
37. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary hypertension in systemic lupus erythematosus.
Simonson JS; Schiller NB; Petri M; Hellmann DB
J Rheumatol; 1989 Jul; 16(7):918-25. PubMed ID: 2769664
[TBL] [Abstract][Full Text] [Related]
39. Skin denervation and cutaneous vasculitis in systemic lupus erythematosus.
Tseng MT; Hsieh SC; Shun CT; Lee KL; Pan CL; Lin WM; Lin YH; Yu CL; Hsieh ST
Brain; 2006 Apr; 129(Pt 4):977-85. PubMed ID: 16415307
[TBL] [Abstract][Full Text] [Related]
40. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
Tam LS; Fan B; Li EK; Thomas GN; Yim SF; Haines CJ; Tomlinson B
J Rheumatol; 2003 Jul; 30(7):1479-84. PubMed ID: 12858444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
